Table 1.

Study schedule for data collection measures and time points

Study variable	Sample	Measure	Baseline	clinic visit	4 weeks	LT F/Ug
Eligibility	All subjects	Eligibility assessment	Prior to enrollment
Non-participation		Recruitment issues	Prior to enrollment
Demographics		Participant characteristicsc	X
Mental health		MINIc, d	X
		EPDSb, e and STAIb, f	X		X	X
Decisional conflict		Decisional Conflict Scaleb	X		X
Knowledge		Knowledge Questionnaireb	X		X
Adherence		Website use and Chart reviewa			X	X
Patient-provider		Audiotaped clinic visitb		X
Decision		Health Service Questionnairec	X		X	X
Participant views	PDA only	Acceptability Questionnairea			X
Provider views	Providers	Provider Perspective Surveya				Xh

^aFeasibility; ^bEfficacy; ^cCovariate; ^dMini Neuropsychiatric Interview; ^eEdinburgh Postnatal Depression Scale; ^fState-Trait Anxiety Inventory; ^g LT F/U = long-term follow-up: at 12 weeks postpartum (for women enrolled while pregnant) or 6 months after baseline assessment (for women enrolled while planning a pregnancy); ^hCollected only after all other subject data collection is complete. PDA patient decision aid